Legal Representation
Attorney
Sarah Matthews
USPTO Deadlines
Next Deadline
16 days remaining
Published for Opposition
Due Date
July 24, 2025
Extension Available
Until August 24, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
16 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 24, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jun 24, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jun 18, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| May 24, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| May 23, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| May 23, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| May 23, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 22, 2025 | RFNT | P | REFUSAL PROCESSED BY IB |
| Jan 31, 2025 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Jan 31, 2025 | RFRR | P | REFUSAL PROCESSED BY MPU |
| Dec 30, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Dec 29, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Dec 27, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Sep 9, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Sep 9, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sep 5, 2024 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 042
Pharmaceutical drug development; drug discovery services, namely, development of pharmaceutical preparations and medicines; pharmaceutical research and development; drug development services; development of pharmaceuticals; development of pharmaceutical preparations and medicines; research and development of new products for the pharmaceutical industry; research and development services of new pharmaceutical products; scientific research and development; research to develop new products; conducting early evaluations in the field of new pharmaceuticals; research in the field of pharmaceuticals; research and development services for the pharmaceutical industry; biochemical research and development; laboratory research in the field of pharmaceuticals; scientific research in the field of pharmacogenomics; research and development services in the field of pharmaceutical preparations; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information about medical and scientific research in the field of pharmaceuticals; product development consultancy for inventors in the field of molecular biology; research and development in the field of biochemistry
Class 044
Providing information relating to drugs, namely, providing medical information to medical professionals in the form of reports in the field of pharmaceutical interactions; drug information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; provision of information relating to drugs, namely, providing medical information to medical professionals in the form of reports in the field of pharmaceutical interactions; advisory services relating to drugs, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
Additional Information
Pseudo Mark
MASS AFFINITY
Classification
International Classes
042
044